Physiopathology, Diagnosis, and Treatment of Diabetes Insipidus

Reference work entry
Part of the Endocrinology book series (ENDOCR)

Abstract

Diabetes insipidus (DI) is a clinical disorder characterized by an excessive hypotonic and diluted urine output. There are four main mechanisms involved in the pathophysiology of DI: (1) central DI (CDI), when the main alteration occurs in the hypothalamus or posterior pituitary and an insufficient amount of the antidiuretic hormone (ADH or AVP) is synthesized or released; (2) nephrogenic DI (NDI), when the kidney does not respond correctly to AVP; (3) transient DI of pregnancy, where an altered AVP metabolism occurs, presumably during a limited period of time; and (4) primary polydipsia, where the initial pathogenic mechanism is related to the intake of fluid, and not as much in its excretion. Consideration of the basic physiopathologic mechanisms involved in AVP regulation enables subsequent understanding of the potential diagnostic and treatment alternative tools for a patient with DI. In this chapter, we will thoroughly revise the different clinical settings of DI, and we will discuss the algorithms that need to be followed for a correct approach and management of patients with this syndrome.

Keywords

Diabetes insipidus Central diabetes insipidus Nephrogenic diabetes insipidus Desmopressin, pituitary surgery Aquaporin Primary polydipsia Arginine-vasopressin Antidiuretic hormone 

References

  1. Behl T, Kotwani A, Kaur I, Goel H. Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus. Eur J Pharmacol. 2015;755:27–33.CrossRefPubMedGoogle Scholar
  2. Bichet DG. The Posterior Pituitary. In: Melmed S, editor. The Pituitary. 3rd ed; 2011. p. 261–99.CrossRefGoogle Scholar
  3. Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev. Nephrol. 2015;11:576–88.CrossRefPubMedGoogle Scholar
  4. Bonfrate L, Procino G, Wang DQH, Svelto M, Portincasa P. A novel therapeutic effect of statins on nephrogenic diabetes insipidus. J Cell Mol Med. 2015;19:265–82.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Christ-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016;12:168–76.CrossRefPubMedGoogle Scholar
  6. Christ-Crain M, Morgenthaler NG, Fenske W. Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. Best Pract Res Clin Endocrinol Metab. 2016;30:235–47.CrossRefPubMedGoogle Scholar
  7. Crowley RK, Sherlock M, Agha A, Smith D, Thompson CJ. Clinical insights into adipsic diabetes insipidus: A large case series. Clin Endocrinol (Oxf). 2007;66:475–86.Google Scholar
  8. Fenske W, Allolio B. Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab. 2012;97:3426–37.CrossRefPubMedGoogle Scholar
  9. Hannon MJ, Finucane FM, Sherlock M, Agha A, Thompson CJ. Clinical review: Disorders of water homeostasis in neurosurgical patients. J Clin Endocrinol Metab. 2012;97:1423–33.CrossRefPubMedGoogle Scholar
  10. Lamas C, Del Pozo C, Villabona C. Clinical guidelines for management of diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion after pituitary surgery. Endocrinol Nutr. 2014;61:e15–24.CrossRefPubMedGoogle Scholar
  11. Loh JA, Verbalis JG. Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab. 2007;6:489–94.CrossRefGoogle Scholar
  12. Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DH. Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med. 1970;73:721–9.CrossRefPubMedGoogle Scholar
  13. Oiso Y, Robertson GL, Nørgaard JP, Vinter Juul K. Treatment of Neurohypophyseal Diabetes Insipidus. J Clin Endocrinol Metab. 2013;98:3958–67.CrossRefPubMedGoogle Scholar
  14. Scranton RA, Baskin DS. Impaired Pituitary Axes Following Traumatic Brain Injury. J Clin Med. 2015;4:1463–79.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Turkkahraman D, Saglar E, Karaduman T, Mergen H. AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus. Pituitary. 2015;18:898–904.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Endocrinology, Hospital Universitario La PrincesaInstituto de Investigación Princesa, Universidad AutónomaMadridSpain

Personalised recommendations